Successful use of amantadine in treatment of malignant neuroleptic syndrome
Blümlein, G.
Psychiatrische Praxis 24(5): 257-258
1997
ISSN/ISBN: 0303-4259 PMID: 9417555 Document Number: 478492
Document emailed within 1 workday
Related Documents
Rojtman, M.; Apter, E.; Lahav, S.; Tiano, S. 1981: Amantadine in malignant neuroleptic syndrome Harefuah 100(7): 333Mueller, P.S.; Vester, J.W.; Fermaglich, J. 1983: Neuroleptic malignant syndrome. Successful treatment with bromocriptine JAMA 249(3): 386-388
McCarron, M.M.; Boettger, M.L.; Peck, J.J. 1982: A case of neuroleptic malignant syndrome successfully treated with amantadine Journal of Clinical Psychiatry 43(9): 381-382
Tsai, M-Chang.; Huang, T-Lai. 2010: Severe neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a case report Chang Gung Medical Journal 33(5): 576-580
Lavie, C.J.; Olmsted, T.R.; Ventura, H.O.; Lepler, B.J. 1986: Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine 80(3): 171-178
Sakkas, P.; Davis, J.M.; Janicak, P.G.; Wang, Z.Y. 1991: Drug treatment of the neuroleptic malignant syndrome Psychopharmacology Bulletin 27(3): 381-384
Guerrero, R.M.; Shifrar, K.A. 1988: Diagnosis and treatment of neuroleptic malignant syndrome Clinical Pharmacy 7(9): 697-701
Emborg, C. 1999: Neuroleptic malignant syndrome after treatment with olanzapine Ugeskrift for Laeger 161(10): 1424-1425
Leikin, J.B.; Baron, S.; Engle, J.; Zell, M.; Hryhorczuk, D.O. 1988: Treatment of neuroleptic malignant syndrome with diphenhydramine Veterinary and Human Toxicology 30(1): 58-59
Bukowczyk, A.; Wasik, A.; Horodnicki, J. 1974: Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs Psychiatria Polska 8(2): 143-148
Gram, L.F. 2000: Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine Ugeskrift for Laeger 162(13): 1914-1915
Fernández, M.; Lago, L.; Alonso, M.Gema.; Guede, A.; Benavente, J.Luis.; Olivares, J.M. 2018: Serotonin syndrome versus neuroleptic malignant syndrome: a case report Actas Espanolas de Psiquiatria 46(2): 68-74
Till, E.; Vucković, S.; Lisulov, R.; Nedić, A. 1989: The neuroleptic malignant syndrome Medicinski Pregled 42(11-12): 419-423
Müller, T.; Becker, T.; Fritze, J. 1989: Neuroleptic malignant syndrome Deutsche Medizinische Wochenschrift 114(11): 442-443
Casas Fernández-Tejerina, J.; Pérez de Diego, I.; Estrada Castrillo, P.; Merino Angulo, J. 1987: Neuroleptic malignant syndrome Revista Clinica Espanola 180(7): 407-408
Segado Soriano, A.; López Gonzalez-Cobos, C.; Villalba Garciá, M.V.; Gil Gómez, J.; Muiño Miguez, A.; Millan Núñez-Cortés, J. 1997: Malignant neuroleptic syndrome Anales de Medicina Interna 14(5): 231-235
Suchanová, L. 1985: Malignant neuroleptic syndrome Ceskoslovenska Psychiatrie 81(2): 91-95
Johannessen, J.O.; Bergrem, H. 1989: Neuroleptic malignant syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 109(6): 696-697
Kishida, I.; Furuno, T.; Kawanishi, C. 2012: Neuroleptic malignant syndrome (NMS) Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 6): 612-615
Hernández, A.F. 1994: The neuroleptic malignant syndrome Medicina Clinica 103(14): 559